Contact
searchSearch
HMP Global

Thrombectomy: Features

Figure 1
Advertorial
Use of the Penumbra Indigo® System for Femoral Artery Thrombosis
09/16/2025
Diana Puicea, MD; Silvan Omerovic, DO; Prasanna Sengodan, MD
In this case report, A 45-year-old man with a history of polysubstance abuse presented with intractable nausea and vomiting. Angiography confirmed left anterior descending patency but with significant thrombus burden.
In this case report, A 45-year-old man with a history of polysubstance abuse presented with intractable nausea and vomiting. Angiography confirmed left anterior descending patency but with significant thrombus burden.
In this case report, A...
09/16/2025
Vascular Disease Management
Advertorial
Managing Acute Limb Ischemia With Penumbra Lightning Bolt™ Technology
05/16/2025
Vascular surgeon Katherine Teter, MD, from Hackensack Meridian Medical Group in New Jersey, discusses managing acute limb ischemia with the Penumbra Lightning Bolt™ CAVT system.
Vascular surgeon Katherine Teter, MD, from Hackensack Meridian Medical Group in New Jersey, discusses managing acute limb ischemia with the Penumbra Lightning Bolt™ CAVT system.
Vascular surgeon Katherine...
05/16/2025
Vascular Disease Management
Aspiration Thrombectomy
US Aspiration Thrombectomy Market Sees Rapid Growth in Recent Years, says GlobalData
04/30/2025
28 April 2025—Acute ischemic strokes afflict millions of people across the world every year, and the incidence of this life-threatening medical event continues to rise, driven by higher rates of hypertension and other comorbidities. The clots...
28 April 2025—Acute ischemic strokes afflict millions of people across the world every year, and the incidence of this life-threatening medical event continues to rise, driven by higher rates of hypertension and other comorbidities. The clots...
28 April 2025—Acute ischemic...
04/30/2025
Vascular Disease Management
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Interview
STRIDE Study: When ALI Is Treated With Mechanical Aspiration Thrombectomy, Race, Not Sex, Is Associated With Adverse Outcomes
03/05/2025
Alex Powell, MD
VDM spoke with Dr Powell to discuss the surprising results from the STRIDE study, which looked at the use of the Indigo Aspiration System (Penumbra) for acute limb ischemia.
VDM spoke with Dr Powell to discuss the surprising results from the STRIDE study, which looked at the use of the Indigo Aspiration System (Penumbra) for acute limb ischemia.
VDM spoke with Dr Powell to...
03/05/2025
Vascular Disease Management
Interview
STRIKE-PE: Interim Analysis of the First 300 Patients Using Lightning Flash
03/05/2025
Brian J. Schiro, MD
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about...
03/05/2025
Vascular Disease Management
Thrombectomy
Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients With Pulmonary Embolism
01/13/2025
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13,...
01/13/2025
Vascular Disease Management
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
The US FDA has approved its IDE application to initiate the QUADRA-PE study (NCT06672510) evaluating the Katana™ Thrombectomy System in patients with acute PE.
The US FDA has approved its IDE application to initiate the QUADRA-PE study (NCT06672510) evaluating the Katana™ Thrombectomy System in patients with acute PE.
The US FDA has approved its IDE...
11/04/2024
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Peripheral IVL
Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter Launched in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions
09/16/2025
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin...
09/16/2025
Cath Lab Digest
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Robotic Systems
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The LIBERTY pivotal study showed 100% success in the robotic navigation to target, and zero device-related adverse events. The study also showed a 92% relative reduction in physician radiation exposure.
The LIBERTY pivotal study showed 100% success in the robotic navigation to target, and zero device-related adverse events. The study also showed a 92% relative reduction in physician radiation exposure.
The LIBERTY pivotal study showed...
09/08/2025
Cath Lab Digest
PAD Pulse Alliance
Peripheral Artery Disease (PAD) Awareness Month Urges Screening and Advocacy in National Effort to Prevent Amputations
09/04/2025
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed...
09/04/2025
Cath Lab Digest
Pulmonary Embolism
Imperative Care Announces FDA Clearance of Symphony Thrombectomy System, the First Large-Bore Continuous Vacuum System for Treatment of Pulmonary Embolism
09/04/2025
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use...
09/04/2025
Cath Lab Digest
Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
News
Final Patient Treated in ZENITH® FENESTRATED+ Endovascular Graft Clinical Study
08/28/2025
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL...
08/28/2025
Vascular Disease Management
Bioresorbable Scaffolds
Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System Receives CE Mark, Pioneering a New Era in Peripheral Vascular Treatment
08/26/2025
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked...
08/26/2025
Cath Lab Digest
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use